NASDAQ •
Healthcare •
Medical Devices •
Quote as of 05/05/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization596.64 mln
Float96.92 mln
Earnings Date05/07/2026
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-3.29
Reliable
Relative Strength
74
/ 100
Outperforming
Debt / Equity
0.07
Debt-free
ROE
-17.76
Negative
Dividend Yield
0.00%
No dividend
Business Description
Founded in 1992 and headquartered in Fremont, California, Cytek Biosciences develops and sells instruments, software, and reagents that help scientists study cells in detail for biomedical research and clinical use. The company's product lineup includes a range of flow cytometers, imaging systems, and cell analyzers sold under the Cytek, Amnis, and Guava brands, along with supporting software and consumables. Cytek serves pharmaceutical companies, academic institutions, and contract research organizations, reaching customers through its own sales teams in North America, Europe, China, and the Asia-Pacific region, as well as through third-party distributors elsewhere in the world.